290 related articles for article (PubMed ID: 8157953)
21. Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
Nisini R; Matricardi PM; Fattorossi A; Biselli R; D'Amelio R
Eur J Immunol; 1992 Aug; 22(8):2033-9. PubMed ID: 1353448
[TBL] [Abstract][Full Text] [Related]
22. Deletion of peripheral V beta 14+ T cells by Mtv-2-encoded viral superantigen preceded by blastogenesis and DNA synthesis but not by specific expansion.
Nakano H; Yoshimoto T; Nariuchi H; Kakiuchi T; Matsuzawa A
Cell Immunol; 1996 Mar; 168(2):281-90. PubMed ID: 8640876
[TBL] [Abstract][Full Text] [Related]
23. V alpha domain modulates the multiple topologies of mouse T cell receptor V beta20/staphylococcal enterotoxins A and E complexes.
Bravo de Alba Y; Marche PN; Cazenave PA; Cloutier I; Sekaly RP; Thibodeau J
Eur J Immunol; 1997 Jan; 27(1):92-9. PubMed ID: 9022003
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of antigen-specific T cell activation by staphylococcal enterotoxins.
Dowd JE; Jenkins RN; Karp DR
J Immunol; 1995 Feb; 154(3):1024-31. PubMed ID: 7822779
[TBL] [Abstract][Full Text] [Related]
25. Exogenous superantigens acutely trigger distinct levels of peripheral T cell tolerance/immunosuppression: dose-response relationship.
Miethke T; Wahl C; Gaus H; Heeg K; Wagner H
Eur J Immunol; 1994 Aug; 24(8):1893-902. PubMed ID: 8056049
[TBL] [Abstract][Full Text] [Related]
26. Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.
Fernández MM; Bhattacharya S; De Marzi MC; Brown PH; Kerzic M; Schuck P; Mariuzza RA; Malchiodi EL
Proteins; 2007 Jul; 68(1):389-402. PubMed ID: 17427250
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
28. Xenogeneic cells and superantigen induce human T-cell activation in the absence of T-cell recognition of xenoantigen.
Diaz LA; Pai R; Endres J; Anthony P; Duzyj C; Bishu S; Morita Y; Fox DA
J Lab Clin Med; 2003 Sep; 142(3):149-57. PubMed ID: 14532902
[TBL] [Abstract][Full Text] [Related]
29. Contribution of the TCR alpha-chain to the differential recognition of bacterial and retroviral superantigens.
Daly K; Nguyen P; Hankley D; Zhang WJ; Woodland DL; Blackman MA
J Immunol; 1995 Jul; 155(1):27-34. PubMed ID: 7602104
[TBL] [Abstract][Full Text] [Related]
30. Superantigens induce primary T cell responses to soluble autoantigens by a non-V beta-specific mechanism of bystander activation.
Rott O; Mignon-Godefroy K; Fleischer B; Charreire J; Cash E
Cell Immunol; 1995 Apr; 161(2):158-65. PubMed ID: 7535195
[TBL] [Abstract][Full Text] [Related]
31. Expression of Mtv-7 sag gene in vivo using a retroviral vector results in selective inactivation of superantigen reactive T cells.
Kang J; Ido E; Pawling J; Beutner U; Huber BT; Hozumi N
J Immunol; 1994 Feb; 152(3):1039-46. PubMed ID: 8301116
[TBL] [Abstract][Full Text] [Related]
32. Clonal heterogeneity of superantigen reactivity in human V beta 6+ T cell clones. Limited contributions of V beta sequence polymorphisms.
Goronzy JJ; Oppitz U; Weyand CM
J Immunol; 1992 Jan; 148(2):604-11. PubMed ID: 1530864
[TBL] [Abstract][Full Text] [Related]
33. Stimulator cell type influences the response of T cells to staphylococcal enterotoxins.
Yagi J; Uchiyama T; Janeway CA
J Immunol; 1994 Feb; 152(3):1154-62. PubMed ID: 7905498
[TBL] [Abstract][Full Text] [Related]
34. Bacterial and retroviral superantigens share a common binding region on class II MHC antigens.
Torres BA; Griggs ND; Johnson HM
Nature; 1993 Jul; 364(6433):152-4. PubMed ID: 8391645
[TBL] [Abstract][Full Text] [Related]
35. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
[TBL] [Abstract][Full Text] [Related]
36. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
McMahon CW; Bogatzki LY; Pullen AM
Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
[TBL] [Abstract][Full Text] [Related]
37. Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
Ardavín C; Waanders G; Ferrero I; Anjuère F; Acha-Orbea H; MacDonald HR
J Immunol; 1996 Oct; 157(7):2789-94. PubMed ID: 8816381
[TBL] [Abstract][Full Text] [Related]
38. Interaction of the T cell receptor with bacterial superantigens.
Gascoigne NR
Semin Immunol; 1993 Feb; 5(1):13-21. PubMed ID: 8467090
[TBL] [Abstract][Full Text] [Related]
39. Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule.
Fernández MM; De Marzi MC; Berguer P; Burzyn D; Langley RJ; Piazzon I; Mariuzza RA; Malchiodi EL
Mol Immunol; 2006 Mar; 43(7):927-38. PubMed ID: 16023209
[TBL] [Abstract][Full Text] [Related]
40. In vivo responses of CD4+ and CD8+ cells to bacterial superantigens.
Herrmann T; Baschieri S; Lees RK; MacDonald HR
Eur J Immunol; 1992 Jul; 22(7):1935-8. PubMed ID: 1623932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
